The Electrospinning Company Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

The Electrospinning Company Ltd. - overview

Established

2010

Location

Didcot, Oxfordshire, UK

Primary Industry

Medical Devices & Equipment

About

The Electrospinning Company Ltd. specializes in the design and manufacture of advanced nanofibrous biomaterials and coatings aimed at enhancing the performance of medical devices. Founded in 2010 in Didcot, UK, The Electrospinning Company Ltd. focuses on creating innovative solutions for the medical device industry.


The company has undergone strategic advancements to improve its operational capabilities. The current CEO is Ann Kramer, who has overseen the company’s growth since its inception. As of March 31, 2021, The Electrospinning Company raised GBP 4. 30 million in a funding round led by Confluent Medical Technologies, which has brought the total amount raised to GBP 4.


30 million. The company’s valuation is currently GBP 17. 775 million. The Electrospinning Company specializes in the development of advanced biomaterials for medical applications, including proprietary technologies like Mimetix®, Kalyptix®, Symatix®, and Caladrix®.


Their product range includes resorbable and non-resorbable membranes for tissue regeneration and long-term implantation, as well as biosynthetic membranes that improve biocompatibility. The company services a diverse clientele, including medical device manufacturers and R&D departments across North America, Europe, and parts of Asia, aiming to enhance patient outcomes through innovative materials. In the most recent year of 2022, The Electrospinning Company reported a revenue of GBP 1,533,192. 50 and an EBITDA of GBP -1,461,743.


90. Their revenue generation primarily comes from B2B transactions with medical device manufacturers, involving tailored electrospun materials and multi-year contracts for proprietary products such as Mimetix® and Caladrix®. Following the funding raised on March 31, 2021, The Electrospinning Company plans to invest in enhancing its capabilities through semi-automation and improved materials processing systems. The company is targeting expansion into new geographic markets, focusing on further penetration in North America and Europe within the next two years.


These initiatives aim to strengthen operational efficiency and broaden market reach, leveraging the recent funding to support these strategic goals.


Current Investors

Angels 5K, Newable, Minerva's Business Angel Network

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Equipment Distributors, Biomaterials

Website

www.electrospinning.co.uk

Company Stage

Series A

Total Amount Raised

Subscriber access only

The Electrospinning Company Ltd. - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

The Electrospinning Company Ltd. - financials

Fiscal Year EndedJun 30, 2011Jun 30, 2012Jun 30, 2013Jun 30, 2014Jun 30, 2015Jun 30, 2016Jun 30, 2017Jun 30, 2018Jun 30, 2019Jun 30, 2020Jun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024
Revenue (USD)--------------
% Revenue Growth (YoY)--------------
EBITDA (USD)--------------
Operating Income (USD)--------------
Operating Margin--------------
% EBITDA Margin--------------
NET Income (USD)(98,128)(100,129)(76,755)(65,200)(76,075)(225,473)-(269,565)-(748,515)(1,257,566)---
% Net Margin--------------

The Electrospinning Company Ltd. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.